person
Jose Juan R. R.
- Country
- Spain
- Department
- Servicio de Hematologia
Research Overview
assignment
7
Clinical Trials ·
- Phase 1/2 Study of Subcutaneous Blinatumomab in Adults and Adolescents with Relapsed/Refractory or MRD+ B-cell Precursor Acute Lymphoblastic Leukemia
- Phase 2 Multicenter Trial of Mesenchymal Stromal Cells MC0518 vs. Best Available Therapy in Pediatric Steroid-Refractory Acute Graft-Versus-Host Disease
- Phase 2 Evaluation of Narsoplimab in Pediatric Patients with High-Risk Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy
location_city
2
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
60
Sites with multiple studies
Has run more than one trial at 60 of 156 partner sites.
Specializations
Hematologic Malignancies
This investigator specializes in treating various blood cancers, with particular focus on chronic lymphocytic leukemia, acute lymphoid leukemia, and acute myeloid lymphoma.
- Advanced therapy research in CD19+ malignancies
- Novel therapeutic approaches for resistant leukemias
- Management of myelodysplastic syndromes
Transplant Complications
The investigator has extensive experience in managing post-transplant complications, particularly acute graft-versus-host disease and transplant-associated thrombotic microangiopathy.
- Gastrointestinal GVHD treatments
- Steroid-refractory GVHD management
- High-risk transplant complications
Innovative Therapies
The investigator works with cutting-edge treatments including cellular therapies and novel biological agents for transplant-related conditions.
- Microbiota-based therapeutics
- Targeted immunotherapy approaches
- Combination therapy strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.